PANEL
About the webinar / panel
3D Bioprinting has proven to be a promising approach and a superior tool in the field of tissue engineering and regenerative medicine.
While the growth of bioprinting has been enormous in research and development, it remains to be seen when it can replace traditional treatments in clinical applications.
In this panel, we have brought together panelists, from biomaterial scientists and technology experts to experts in regulations. Together they will provide great insights as we seek to explore answers to the question: “Where are we in terms of clinical translation?”
Panelists
Prof. Massimiliano Papi
Associate Professor at Università Cattolica del Sacro Cuore
Dr. Christofer Troedsson
Chief Executive Officer at Ocean TuniCell AS
Prof. Kenneth Dalgarno
Professor of Manufacturing Engineering at Newcastle University
Dr. Christophe Marquette
Coordinator at 3d.FAB at Université Claude Bernard Lyon 1.
Moderator
Dr. Itedale Namro
Chief Scientic Officer, CELLINK